Rosen Law Firm To Lead Investor Suit Against Botox Rival

Source Node: 1084992
By Katryna Perera (September 17, 2021, 9:42 PM EDT) — The Rosen Law Firm on Friday was appointed class counsel in a shareholder action against medical aesthetics company Evolus Inc. that was filed after the company’s share price fell when it was barred it from importing and selling its alternative to Botox in the United States for 21 months.

A New York federal judge appointed the firm and selected investor Raja Ahmad as the lead plaintiff, saying that Ahmad had alleged the greatest loss and the largest financial interest among the plaintiffs. According to the order, Ahmad has claimed a loss of approximately $748,000.

The U.S. International Trade Commission ordered the…

Source: https://www.law360.com/ip/articles/1423029?utm_source=rss&utm_medium=rss&utm_campaign=section

Time Stamp:

More from Law360: Intellectual Property